Services

I have recommended the use of JSB’s services for biotechnology companies that did not have a fully developed business development department, in one case for the search of an M&A target and in the other for the out-licensing of an R&D project. I like both the well-structured approach JSB uses for the projects at hand, as well as the respect they receive from relevant companies.”
— Rolf Stahel
Former CEO, Shire
JSB has extensive contacts within both the Biotech and Pharma industries and used these to rapidly identify a short list of potential partners. The process turned to M&A rather quickly and JSB is unique in that they could also serve as our M&A advisor in the transaction. They helped us run the diligence process to get to a successful sale of the assets in record time. I am pleased with their performance and would gladly use them in future projects.”
— Gary Lyons
Former Chairman, NeurogesX
JSB Partners is the ideal firm for biotechnology companies to retain because of JSB’s reputation for working very closely at the beginning of an assignment with senior management and boards to precisely define the transaction that meets the client’s strategic needs. In addition, the firm is unique in its deep knowledge of the US and EU markets, having executed many cross-border transactions.”
— Ken Bate
Chairman, Cubist
JSB employs strict process management and a professional approach. In addition, it is vital to have an independent third party advising you - not one that provides wishful thinking, but a truly realistic view. This is what sets them apart from other advisors.”
— Stefan Weber
CEO, Newron
JSB-Partners, with their very efficient partnering process, enabled a successful closing of the divestment of this very complex and heterogeneous package of oncology projects exactly within the anticipated timeframe. They perfectly complemented our internal resources and helped us to achieve excellent results.”
— Thomas Trah
VP, Strategic Partnering, Business Development, Nycomed
Due to the great support of the experienced team and the extremely effective and efficient partnering process of JSB-Partners, Nycomed managed to close the transaction with Sepracor at favorable terms for both parties and within a very short timeframe.”
— Christian Kanzelmeyer
Corporate VP, Head Global Licensing, Nycomed

Deep Insights into Every Facet of the Deal

JSB-Partners serves as a versatile, trusted, and results-oriented advisor to a select group of clients in the biotechnology and pharmaceutical industries, who range from small start-ups to mature global organizations. With deep expertise in the life science industry as well as the world of specialized banking services, our only agenda is optimizing the short- to long-term value of our clients.

We are fully committed to the biotechnology and pharmaceutical industries, regardless of market cycles. Our key types of engagements involve:

Product Partnerships — Product partnering or licensing arrangements that provide resources and do not dilute the ownership stake held by existing shareholders
Mergers and Acquisitions — Purchases, sales, and strategic combinations of corporate entities
Private Placements and Public Underwritings — private financings including private investments, private investment in public equity (PIPEs) and registered direct offerings (RDOs); public underwritings – including initial public offerings (IPOs), secondary offerings and confidentially marketed public offerings (CMPOs) are provided through our exclusive partnership with Noble Life Science Partners, a division of Noble Financial Capital Markets with a history of successful financing transactions. Noble Life Science Partners also provides private funding on a principal basis through its merchant banking activities.

To learn more, or to begin discussions, please contact us.